PANCAR
Live / Allowed — Fourth extension granted (statement of use) (as of 13 Oct 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 04 Jan 2024 filing date already counts against anyone who files later.
Record
- Serial number
- 98342248
- Mark type
- Word mark
- Filed
- 04 Jan 2024
- Published for opposition
- 03 Sept 2024
- Attorney of record
- Jonathan M. Gelchinsky
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment and prevention of autoimmune, immune mediated, and inflammatory diseases and disorders, nucleic acid pharmaceuticals, medicines, biologics, biotherapeutics, biosimilars and therapeutics for the treatment and prevention of autoimmune, immune mediated, and inflammatory diseases and disorders; pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; pharmaceutical products for the prevention and treatment of cancer; therapeutic vaccines; pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; pharmaceutical preparations for the treatment of immune system related diseases and disorders; therapeutic pharmaceutical for the treatment of autoimmune, immune mediated, and inflammatory diseases and disorders, nucleic acid pharmaceuticals, medicines, biologics, biotherapeutics, biosimilars and therapeutics for the treatment and prevention of autoimmune, immune mediated, and inflammatory diseases and disorders
- Class 042 — Scientific and technological services: Medical and scientific research in the field of nucleic acid pharmaceuticals, medicine, biologics, biotherapeutics, biosimilars and therapeutics
- Class 044 — Medical, beauty and agricultural services: Medical services
Owner
- Orna Therapeutics, Inc., Watertown, MA, US
- Orna Therapeutics, Inc., Watertown, MA, US
Prosecution history
- 14 Oct 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 13 Oct 2026 — SOU EXTENSION 4 GRANTED
- 13 Oct 2026 — SOU EXTENSION 4 FILED
- 13 Oct 2026 — SOU TEAS EXTENSION RECEIVED
- 02 Apr 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 31 Mar 2026 — SOU EXTENSION 3 GRANTED
- 31 Mar 2026 — SOU EXTENSION 3 FILED
- 31 Mar 2026 — SOU TEAS EXTENSION RECEIVED
- 24 Oct 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 23 Oct 2025 — SOU EXTENSION 2 GRANTED
- 23 Oct 2025 — SOU EXTENSION 2 FILED
- 23 Oct 2025 — SOU TEAS EXTENSION RECEIVED
- 04 Apr 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 04 Apr 2025 — SOU EXTENSION 1 GRANTED
- 03 Apr 2025 — SOU EXTENSION 1 FILED